Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
G&E Herbal
G&E Herbal
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
G&E Herbal
Stock Price
NT$58.3
2024-10-29
Market Capitalization
NT$3.4 B
2024-10-29
Revenue
NT$309.1 M
FY, 2025
G&E Herbal Summary
Company Summary
Overview
G&E Herbal (德英生物科技股份有限司) biopharmaceutical company that manufactures and distributes health care products. It offers dietary supplements, conventional drugs, cosmetics, capsules, and other products.
Type
Public
Status
Active
Founded
2002
Website
https://www.geherbs.com
Sectors
Healthcare
cosmetics
drug development
pharma
supplements
Homepage
facebook
Table of Contents
Financials
Competitors
G&E Herbal Financials
Summary Financials
Revenue (FY, 2025)
NT$309.1M
Gross profit (FY, 2025)
NT$272.2M
Net income (FY, 2025)
NT$139.2M
Cash (FY, 2025)
NT$78.4M
EBIT (FY, 2025)
NT$152.3M
Enterprise value
$3.3B
Competitors and Similar Companies
Genome & Company
Healthcare - Private
Laboratorio Reig Jofre
Healthcare - Public
Farmalider
Healthcare - Private
Tien Liang BioTech
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top